Across TCGA pan-cancer cohorts, PEX26 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated PEX26 data layer compared with 22 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher PEX26 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated PEX26 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and LUAD show a favorable association.

CCRCC, UCEC, and LSCC are the cancer types where PEX26 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Median	All	0.970	0.501	.004	11	view →
UCEC	DFS	Quartile	III,IV	0.154	1.000	.038	10	view →
LSCC	DFS	Median	All	0.495	0.907	.014	6	view →
LUAD	OS	Median	III,IV	1.000	0.360	.042	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: PEX26 tumor-vs-normal RNA expression · all PEX26 data types